GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 11, 2013, Pages 1317-1324

  Li, Mengjie ^a   Wang, Xufang ^b   Aa, Jiye ^a   Qin, Weisong ^b   Zha, Weibin ^a   Ge, Yongchun ^b   Liu, Linsheng ^a   Zheng, Tian ^a   Cao, Bei ^a   Shi, Jian ^a   Zhao, Chunyan ^a   Wang, Xinwen ^a   Yu, Xiaoyi ^a   Wang, Guangji ^a   Liu, Zhihong ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Gas chromatography mass spectrometry; Metabonomics; Tricarboxylic acid cycle

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ACONITIC ACID; ALBUMIN; ARGININE; CITRIC ACID; CORIOLIC ACID; ERYTHRONATE; ETHANOLAMINE; GLUCOSE; GLUCURONIC ACID; LYSINE; MALIC ACID; METHIONINE; PALMITIC ACID; STEARIC ACID; SUCCINIC ACID; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG; VALINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GAS CHROMATOGRAPHY; GAS CHROMATOGRAPHY TIME OF FLIGHT MASS SPECTROMETRY; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; LIPID METABOLISM; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; URINARY EXCRETION; URINE LEVEL; URINE PH;

EID: 84878648388     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00536.2012     Document Type: Article

References (40)

1. A J, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, Marklund SL, Moritz T. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem 77: 8086-8094, 2005.
2. Breyer MD, Bottinger E, Brosius FC, Coffman TM 3rd, Harris RC, Heilig CW, Sharma K. Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005.
3. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo-Perin P. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 26: 2150-2155, 2003.
4. Cao B, Aa J, Wang G, Wu X, Liu L, Li M, Shi J, Wang X, Zhao C, Zheng T, Guo S, Duan J. GC-TOFMS analysis of metabolites in adherent MDCK cells and a novel strategy for identifying intracellular metabolic markers for use as cell amount indicators in data normalization. Anal Bioanal Chem 400: 2983-2993, 2011.
5. Carpena MP, Rados DV, Sortica DA, Souza BM, Reis AF, Canani LH, Crispim D. Genetics of diabetic nephropathy. Arq Bras Endocrinol Metabol 54: 253-261, 2010.
6. Cohen AH, Nast CC, Adler SG, Kopple JD. Clinical utility of kidney biopsies in the diagnosis and management of renal disease. Am J Nephrol 9: 309-315, 1989.
7. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80: 1258-1270, 2011.
8. Eriksson L, Johansson E, Kettaneh-Wold N. Multi- and megavariate data analysis principles and applications. J Chemom 16: 262-262, 2002.
9. Han LD, Xia JF, Liang QL, Wang Y, Wang YM, Hu P, Li P, Luo GA. Plasma esterified and nonesterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy. Anal Chim Acta 689: 85-91, 2011.
10. Hinder LM, Vivekanandan-Giri A, McLean LL, Pennathur S, Feld-man EL. Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes. J Endocrinol 216: 1-11, 2013.
11. Hu Y, Kaisaki PJ, Argoud K, Wilder SP, Wallace KJ, Woon PY, Blancher C, Tarnow L, Groop PH, Hadjadj S, Marre M, Parving HH, Farrall M, Cox RD, Lathrop M, Vionnet N, Bihoreau MT, Gauguier D. Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus. BMC Med Genomics 2: 41, 2009.
12. Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice. Exp Clin Endocrinol Diabetes 115: 571-576, 2007.
13. Jiye A, Huang Q, Wang G, Zha W, Yan B, Ren H, Gu S, Zhang Y, Zhang Q, Shao F, Sheng L, Sun J. Global analysis of metabolites in rat and human urine based on gas chromatography/time-of-flight mass spec-trometry. Anal Biochem 379: 20-26, 2008.
14. Jonsson P, Johansson AI, Gullberg J, Trygg J, AJ, Grung B, Mark-lund S, Sjostrom M, Antti H, Moritz T. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal Chem 77: 5635-5642, 2005.
15. Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 49: 22-31, 2000.
16. Liu L, Aa J, Wang G, Yan B, Zhang Y, Wang X, Zhao C, Cao B, Shi J, Li M, Zheng T, Zheng Y, Hao G, Zhou F, Sun J, Wu Z. Differences in metabolite profile between blood plasma and serum. Anal Biochem 406: 105-112, 2010.
17. Maher AD, Crockford D, Toft H, Malmodin D, Faber JH, McCarthy MI, Barrett A, Allen M, Walker M, Holmes E, Lindon JC, Nicholson JK. Optimization of human plasma 1H NMR spectroscopic data processing for high-throughput metabolic phenotyping studies and detection of insulin resistance related to type 2 diabetes. Anal Chem 80: 7354-7362, 2008.
18. Makinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, Kaski K, Groop PH, Ala-Korpela M. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 4: 167, 2008.
19. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH. Diabetic nephropathy. Diabetes Care 26, Suppl 1: S94-98, 2003.
20. Ozer JS. A guidance for renal biomarker lead optimization and use in translational pharmacodynamics. Drug Discov Today 15: 142-147, 2010.
21. Paone DB, Meyer LE. The effect of biopsy on therapy in renal disease. Arch Intern Med 141: 1039-1041, 1981.
22. Parton LE, McMillen PJ, Shen Y, Docherty E, Sharpe E, Diraison F, Briscoe CP, Rutter GA. Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis. Am J Physiol Endocrinol Metab 291: E982- E994, 2006.
23. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 341: 1127-1133, 1999.
24. Selby JV, FitzSimmons SC, Newman JM, Katz PP, Sepe S, Showstack J. The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control. JAMA 263: 1954-1960, 1990.
25. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284: F1138-F1144, 2003.
26. Spegel P, Malmgren S, Sharoyko VV, Newsholme P, Koeck T, Mulder H. Metabolomic analyses reveal profound differences in glycolytic and tricarboxylic acid cycle metabolism in glucose-responsive and -unresponsive clonal beta-cell lines. Biochem J 435: 277-284, 2011.
27. Suhre K, Meisinger C, Doring A, Altmaier E, Belcredi P, Gieger C, Chang D, Milburn MV, Gall WE, Weinberger KM, Mewes HW, Hrabe de Angelis M, Wichmann HE, Kronenberg F, Adamski J, Illig T. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5: e13953, 2010.
28. Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM, Herman WH. Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24: 1560-1566, 2001.
29. The United States Renal Data System. The USRDS and its products. Am J Kidney Dis 32: S20-37, 1998.
30. Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, Meer E, Peti-Peterdi J. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 118: 2526-2534, 2008.
31. Tsaih SW, Pezzolesi MG, Yuan R, Warram JH, Krolewski AS, Korstanje R. Genetic analysis of albuminuria in aging mice and concordance with loci for human diabetic nephropathy found in a genome-wide association scan. Kidney Int 77: 201-210, 2010.
32. van der Kloet FM, Tempels FW, Ismail N, van der Heijden R, Kasper PT, Rojas-Cherto M, van Doorn R, Spijksma G, Koek M, van der Greef J, Makinen VP, Forsblom C, Holthofer H, Groop PH, Reijmers TH, Hankemeier T. Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabo-lomics 8: 109-119, 2012.
33. Wang C, Kong H, Guan Y, Yang J, Gu J, Yang S, Xu G. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mel-litus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem 77: 4108-4116, 2005.
34. Warrack BM, Hnatyshyn S, Ott KH, Reily MD, Sanders M, Zhang H, Drexler DM. Normalization strategies for metabonomic analysis of urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 877: 547-552, 2009.
35. Wold S. Cross-validatory estimation of the number of components in factor and principal components models. Technometris 20: 397-405, 1978.
36. Zerbini G. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 349: 906-908; author reply 906-908, 2003.
37. Zhang J, Yan L, Chen W, Lin L, Song X, Yan X, Hang W, Huang B. Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Anal ChimActa 650: 16-22, 2009.
38. _/_ db/db mice. Am J Physiol Renal Physiol 302: F433-F438, 2012.
39. Zhao L, Liu X, Xie L, Gao H, Lin D. 1H NMR-based metabonomic analysis of metabolic changes in streptozotocin-induced diabetic rats. Anal Sci 26: 1277-1282, 2010.
40. Zhao T, Zhang H, Zhang X, Lu J, Yin T, Liang Q, Wang Y, Luo G, Lan H, Li P. Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease. J Pharm Biomed Anal 60: 32-43, 2012.